helmholtzeyeinstituteРоссийский офтальмологический журналRussian Ophthalmological Journal2072-00762587-5760Real time Publishers10.21516/2072-0076-2022-15-4-156-165helmholtzeyeinstitute-1116Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWSПоражение органа зрения при COVID-19. Часть 1: участие глаза в передаче вируса SARS-CoV-2 и осложнения со стороны переднего отрезкаEye damage in COVID-19. Part 1: Involvement of the eye in SARS-CoV-2 virus transmission and anterior segment complicationshttps://orcid.org/0000-0002-2265-6671КурышеваН. И.KuryshevaN. I.

Наталия Ивановна Курышева — д-р мед. наук, профессор, заведующая кафедрой глазных болезней, заведующая консультативно-диагностическим отделением

ул. Маршала Новикова, д. 23, Москва, 123098

ул. Гамалеи, д. 15, Мос ква, 123098

Natalia I. Kurysheva — Dr. of Med. Sci., professor, head of chair of eye diseases, head of the consultative and diagnostic department

23, Marshal Novikov St., Moscow, 123098

15, Gamaleya St., Moscow, 123098

e-natalia@list.ruhttps://orcid.org/0000-0003-4183-2420ПерерваО. А.PerervaO. A.

Оксана Александровна Перерва — ассистент кафедры глазных болезней, врач-офтальмолог

ул. Маршала Новикова, д. 23, Москва, 123098

ул. Гамалеи, д. 15, Мос ква, 123098

Oksana A. Pererva — assistant of chair of eye diseases, ophthalmologist

23, Marshal Novikov St., Moscow, 123098

15, Gamaleya St., Moscow, 123098

https://orcid.org/0000-0003-3537-6406НикитинаА. Д.NikitinaA. D.

Анастасия Дмитриевна Никитина — ассистент кафедры глазных болезней, врач-офтальмолог

ул. Маршала Новикова, д. 23, Москва, 123098

ул. Гамалеи, д. 15, Мос ква, 123098

Anastasiya D. Nikitina — assistant of chair of eye diseases, ophthalmologist

23, Marshal Novikov St., Moscow, 123098

15, Gamaleya St., Moscow, 123098

Медико-биологический университет инноваций и непрерывного образования ФГБУ ГНЦ РФ — Федеральный биофизический центр им. А.И. Бурназяна ФМБА России; Центр офтальмологии ФМБА России, ФГБУ ГНЦ РФ ФМБЦ им. А.И. Бурназяна ФМБА РоссииРоссияMedical Biological University of Innovations and Continuing Education — A.I. Burnazyan Medical Biophysical Center; Ophthalmological Center, Federal Medical and Biological AgencyRussian Federation202214122022154156165Copyright © Курышева Н.И., Перерва О.А., Никитина А.Д., 20222022Курышева Н.И., Перерва О.А., Никитина А.Д.Kurysheva N.I., Pererva O.A., Nikitina A.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://roj.igb.ru/jour/article/view/1116

Поражение глаза при COVID-19 может развиться на любой стадии заболевания. Вирусная рибонуклеиновая кислота обнаружена в глазных тканях, но роль глаза как пути заражения еще предстоит обосновать. Офтальмологические проявления могут быть характерным признаком COVID-19 или развиться через несколько недель после выздоровления. Офтальмологи должны быть осведомлены о возможных связях офтальмопатологии с SARS-CoV-2 для целенаправленного сбора анамнеза, обнаружения специфических признаков, назначения необходимых анализов и тем самым для снижения уровня распространения инфекции, а также для ранней диагностики и лечения осложнений, угрожающих жизни и зрению. В первой части обзора приводятся сведения о возможном участии глаза в заражении SARS-CoV-2 и распространении инфекции. Рассмотрены клинические проявления поражения переднего отрезка глаза.

In COVID-19, eye damage may develop at any stage of the disease. Viral ribonucleic acid has been found in ocular tissues, but the role of the eye as a route of infection is yet to be substantiated. Ophthalmic manifestations may be a typical feature of COVID-19 infection or they may develop several weeks after recovery. Ophthalmologists should be aware of possible relationships of an ophthalmic pathology with SARS-CoV-2 in order to obtain targeted case history, detect the specific signs, prescribe the necessary tests and thereby reduce the spread of the infection. These relationships are also important for early diagnosis and treatment of complications that threaten the patients’ life and vision. The first part of the review focuses on the possible involvement of the eye in SARS-CoV-2 infection and the spread of infection. Clinical manifestations of the anterior segment damage are considered.

SARS-CoV-2COVID-19осложнения коронавирусной инфекциикоронавирусный конъюнктивитэписклеритSARS-CoV-2COVID-19complications of coronavirus infectioncoronavirus conjunctivitisepiscleritisReferencesНероев В.В., Кричевская Г.И., Балацкая Н.В. COVID-19 и проблемы офтальмологии. Российский офтальмологический журнал. 2020; 13 (4): 99–104. https://doi.org/10.21516/2072-0076-2020-13-4-99-104Neroev V.V., Krichevskaya G.I., Balatskaya N.V. COVID-19 and problems of ophthalmology. Russian ophthalmological journal. 2020; 13 (4): 99–104 (in Russian). https://doi.org/10.21516/2072-0076-2020-13-4-99-104Нероев В.В., Киселева Т.Н., Елисеева Е.К. Офтальмологические аспекты коронавирусной инфекции. Российский офтальмологический журнал. 2021; 14 (1): 7–14. https://doi.org/10.21516/2072-0076-2021-14-1-7-14Neroev V.V., Kiseleva T.N., Eliseeva E.K. Ophthalmological aspects of coronavirus infections. Russian ophthalmological journal. 2021; 14 (1): 7–14 (in Russian). https://doi.org/10.21516/2072-0076-2021-14-1-7-14Тахчиди Х.П., Тахчиди Н.Х., Мовсесян М.Х. COVID-19 в офтальмологической практике. Медицина экстремальных ситуаций. 2020; (4): 53–8. https://doi.org/10.47183/mes.2020.017Takhchidi Kh.P., Takhchidi N.Kh., Movsesian M.Kh. COVID-19 in ophthalmic practice. Extreme Medicine. 2020; (4): 53–8 (in Russian). https://doi.org/10.47183/mes.2020.017Курышева Н.И. Организация офтальмологической помощи в условиях пандемии COVID-19. Москва: ГНЦ ФМБЦ; 2021.Kurysheva N.I. Organization of ophthalmic care in a pandemic of COVID-19. Moscow: GNC FMBC; 2021 (in Russian).Курышева Н.И., Печенкина А.А., Гончарова А.С. Методы обследования больных глаукомой в период пандемии COVID-19. Вестник офтальмологии. 2021; 137 (2): 75–83. https://doi.org/10.17116/oftalma202113702175Kurysheva N.I., Pechenkina A.A., Goncharova A.S. Examination of patients with glaucoma during the COVID-19 pandemic. Vestnik oftal’mologii. 2021; 137 (2): 75–83 (in Russian). https://doi.org/10.17116/oftalma202113702175Cheema M., Aghazadeh H., Nazarali S., et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can. J. Ophthalmol. 2020; 55 (4): e 125-9. https://doi.org/10.1016/j.jcjo.2020.03.003Cheema M., Aghazadeh H., Nazarali S., et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can. J. Ophthalmol. 2020; 55 (4): e 125-9. https://doi.org/10.1016/j.jcjo.2020.03.003Zhang X., Chen X., Chen L., et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul. Surf. 2020; 18 (3): 360–2. https://doi.org/10.1016/j.jtos.2020.03.010Zhang X., Chen X., Chen L., et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul. Surf. 2020; 18 (3): 360–2. https://doi.org/10.1016/j.jtos.2020.03.010Lu C.W., Liu X.F., Jia Z.F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020; 395 (10224): e39. https://doi.org/10.1016/S0140-6736(20)30313-5Lu C.W., Liu X.F., Jia Z.F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020; 395 (10224): e39. https://doi.org/10.1016/S0140-6736(20)30313-5Seah I., Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul. Immunol. Inflamm. 2020; 28 (3): 391–5. https://doi.org/10.1080/09273948.2020.1738501Seah I., Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul. Immunol. Inflamm. 2020; 28 (3): 391–5. https://doi.org/10.1080/09273948.2020.1738501World Health Organization. (2020). Origin of SARS-CoV-2, 26 March 2020. World Health Organization. Available at: https://apps.who.int/iris/handle/10665/332197World Health Organization. (2020). Origin of SARS-CoV-2, 26 March 2020. World Health Organization. Available at: https://apps.who.int/iris/handle/10665/332197Chan J.F., Kok K.H., Zhu Z., et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020; 9 (1): 221–36. https://doi.org/10.1080/22221751.2020.1719902Chan J.F., Kok K.H., Zhu Z., et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020; 9 (1): 221–36. https://doi.org/10.1080/22221751.2020.1719902Jiang R.D., Liu M.Q., Chen Y., et al. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. Cell. 2020; 182: 50–8. https://doi.org/10.1016/j.cell.2020.05.027Jiang R.D., Liu M.Q., Chen Y., et al. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. Cell. 2020; 182: 50–8. https://doi.org/10.1016/j.cell.2020.05.027Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). February 2020. World Health Organization; 2020: 16–24.Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). February 2020. World Health Organization; 2020: 16–24.World Health Organization. (2020). Laboratory testing of 2019 novel coronavirus (2019-nCoV) in suspected human cases: interim guidance, 17 January 2020. World Health Organization. Available at: https://apps.who.int/iris/handle/10665/330676World Health Organization. (2020). Laboratory testing of 2019 novel coronavirus (2019-nCoV) in suspected human cases: interim guidance, 17 January 2020. World Health Organization. Available at: https://apps.who.int/iris/handle/10665/330676Loon S.-C., Teoh S.C.B., Oon L.L.E. et al. The severe acute respiratory syndrome coronavirus in tears. Br. J. Ophthalmol. 2004; 88 (7): 861–3. https://doi.org/10.1136/bjo.2003.035931Loon S.-C., Teoh S.C.B., Oon L.L.E. et al. The severe acute respiratory syndrome coronavirus in tears. Br. J. Ophthalmol. 2004; 88 (7): 861–3. https://doi.org/10.1136/bjo.2003.035931Chan W.M., Yuen K.S., Fan D.S., et al. Tears and conjunctival scrapings for coronavirus in patients with SARS. Br. J. Ophthalmol. 2004; 88 (7): 968–9. https://doi.org/10.1136/bjo.2003.039461Chan W.M., Yuen K.S., Fan D.S., et al. Tears and conjunctival scrapings for coronavirus in patients with SARS. Br. J. Ophthalmol. 2004; 88 (7): 968–9. https://doi.org/10.1136/bjo.2003.039461Yan A. Chinese expert who came down with Wuhan coronavirus after saying it was controllable thinks he was infected through his eyes. China: South China Morning Post. 2020. Available at: https://www.scmp.com/news/china/article/3047394/chinese-expert-who-came-down-wuhan-coronavirus-aftersayingit-was [Accessed 26 June 2020].Yan A. Chinese expert who came down with Wuhan coronavirus after saying it was controllable thinks he was infected through his eyes. China: South China Morning Post. 2020. Available at: https://www.scmp.com/news/china/article/3047394/chinese-expert-who-came-down-wuhan-coronavirus-aftersayingit-was [Accessed 26 June 2020].Lawrenson J.G., Buckley R.J. COVID-19 and the eye. Ophthalmic Physiol. Opt. 2020; 40 (4): 383–8. https://doi.org/10.1111/opo.12708Lawrenson J.G., Buckley R.J. COVID-19 and the eye. Ophthalmic Physiol. Opt. 2020; 40 (4): 383–8. https://doi.org/10.1111/opo.12708Ulhaq Z.S., Soraya G.V. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch. Clin. Exp. Ophthalmol. 2020; 258 (6): 1351–2. https://doi.org/10.1007/s00417-02004695-8Ulhaq Z.S., Soraya G.V. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch. Clin. Exp. Ophthalmol. 2020; 258 (6): 1351–2. https://doi.org/10.1007/s00417-02004695-8Xia J., Tong J., Liu M., Shen Y., Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J. Med. Virol. 2020; 92 (6): 589–94. doi:10.1002/jmv.25725Xia J., Tong J., Liu M., Shen Y., Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J. Med. Virol. 2020; 92 (6): 589–94. doi:10.1002/jmv.25725Wu P., Duan F., Luo C., et al. Characteristics of ocular findings of patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020; 138 (5): 575. doi:10.1001/jamaophthalmol.2020.1291Wu P., Duan F., Luo C., et al. Characteristics of ocular findings of patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020; 138 (5): 575. doi:10.1001/jamaophthalmol.2020.1291Zhou Y., Duan C., Zeng Y., et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020; 127 (7): 982–3. doi:10.1016/j.ophtha.2020.04.028Zhou Y., Duan C., Zeng Y., et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020; 127 (7): 982–3. doi:10.1016/j.ophtha.2020.04.028Zhou Y., Zeng Y., Tong Y., Chen C. Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. MedRxiv.; 2020. doi:10.1101/2020.02.11.20021956Zhou Y., Zeng Y., Tong Y., Chen C. Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. MedRxiv.; 2020. doi:10.1101/2020.02.11.20021956Zou L., Ruan F., Huang M., et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020; 382 (12): 1177–9. doi:10.1056/NEJMc2001737Zou L., Ruan F., Huang M., et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020; 382 (12): 1177–9. doi:10.1056/NEJMc2001737Hong N., Yu W., Xia J., et al. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020; 98 (5): e 649–55. doi:10.1111/aos.14445Hong N., Yu W., Xia J., et al. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020; 98 (5): e 649–55. doi:10.1111/aos.14445Hu Y., Chen T., Liu M., et al. Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct. Acta Ophthalmol. 2020; 98 (8): 859–63. doi:10.1111/aos.14456Hu Y., Chen T., Liu M., et al. Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct. Acta Ophthalmol. 2020; 98 (8): 859–63. doi:10.1111/aos.14456Hui K.P.Y., Cheung M.C., Perera R., et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir. Med. 2020; 8 (7): 687–95. doi:10.1016/S2213-2600(20)30193-4Hui K.P.Y., Cheung M.C., Perera R., et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir. Med. 2020; 8 (7): 687–95. doi:10.1016/S2213-2600(20)30193-4White A.J., Cheruvu S.C., Sarris M., et al. Expression of classical components of the renin-angiotensin system in the human eye. J. Renin Angiotensin Aldosterone Syst. 2015; 16 (1): 59–66. doi:10.1177/1470320314549791White A.J., Cheruvu S.C., Sarris M., et al. Expression of classical components of the renin-angiotensin system in the human eye. J. Renin Angiotensin Aldosterone Syst. 2015; 16 (1): 59–66. doi:10.1177/1470320314549791Sungnak W., Huang N., Becavin C., et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020; 26 (5): 681–7. doi:10.1038/s41591-020-0868-6Sungnak W., Huang N., Becavin C., et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020; 26 (5): 681–7. doi:10.1038/s41591-020-0868-6Lange C., Wolf J., Auw-Haedrich C., et al. Expression of the COVID-19 receptor ACE2 in the human conjunctiva. J. Med. Virol. 2020; 92 (10): 2081–6. doi:10.1002/jmv.25981Lange C., Wolf J., Auw-Haedrich C., et al. Expression of the COVID-19 receptor ACE2 in the human conjunctiva. J. Med. Virol. 2020; 92 (10): 2081–6. doi:10.1002/jmv.25981Ma D., Chen C.B., Jhanji V., et al. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye (Lond). 2020; 34 (7): 1212-9. doi:10.1038/s41433-020-0939-4Ma D., Chen C.B., Jhanji V., et al. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye (Lond). 2020; 34 (7): 1212-9. doi:10.1038/s41433-020-0939-4Leonardi A., Rosani U., Brun P. Ocular surface expression of SARS-CoV-2 receptors. Ocul. Immunol. Inflamm. 2020; 28 (5): 735–8. doi:10.1080/09273948.2020.1772314Leonardi A., Rosani U., Brun P. Ocular surface expression of SARS-CoV-2 receptors. Ocul. Immunol. Inflamm. 2020; 28 (5): 735–8. doi:10.1080/09273 948.2020.1772314Lang J., Yang N., Deng J., et al. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS One. 2011; 6 (8): e23710. doi:10.1371/journal.pone.0023710Lang J., Yang N., Deng J., et al. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS One. 2011; 6 (8): e23710. doi:10.1371/journal.pone.0023710Seah I.Y.J., Anderson D.E., Kang A.E.Z., et al. Assessing viral shedding and infectivity of tears in Coronavirus Disease 2019 (COVID-19) patients. Ophthalmology. 2020; 127 (7): 977–9. doi:10.1016/j.ophtha.2020.03.026Seah I.Y.J., Anderson D.E., Kang A.E.Z., et al. Assessing viral shedding and infectivity of tears in Coronavirus Disease 2019 (COVID-19) patients. Ophthalmology. 2020; 127 (7): 977–9. doi:10.1016/j.ophtha.2020.03.026Xie H.-T., Jiang S.-Y., Xu -K.-K., et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis (Lond). 2020; 92 (1): 23. doi:10.1186/s40662020-00189-0Xie H.-T., Jiang S.-Y., Xu -K.-K., et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis (Lond). 2020; 92 (1): 23. doi:10.1186/s40662020-00189-0Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19. National Center for Immunization and Respiratory Diseases (NCIRD). Division of Viral Diseases. Available at: https://stacks.cdc.gov/view/cdc/86167Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19. National Center for Immunization and Respiratory Diseases (NCIRD). Division of Viral Diseases. Available at: https://stacks.cdc.gov/view/cdc/86167He X., Lau E.H.Y., Wu P., et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020; 26 (5): 672–5. doi:10.1038/s41591-020-0869-5He X., Lau E.H.Y., Wu P., et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020; 26 (5): 672–5. doi:10.1038/s41591-020-0869-5Chen L., Deng C., Chen X., et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020; 98 (8): e 951–9. doi:10.1111/aos.14472Chen L., Deng C., Chen X., et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020; 98 (8): e 951–9. doi:10.1111/aos.14472Chen L., Liu M., Zhang Z., et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br. J. Ophthalmol. 2020; 104 (6): 748–51. doi:10.1136/bjophthalmol-2020-316304Chen L., Liu M., Zhang Z., et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br. J. Ophthalmol. 2020; 104 (6): 748–51. doi:10.1136/bjophthalmol-2020-316304Nayak B., Poddar C., Panigrahi M.K., Tripathy S., Mishra B. Late manifestation of follicular conjunctivitis in ventilated patient following COVID-19 positive severe pneumonia. Indian J. Ophthalmol. 2020; 68 (8): 1675–7. doi:10.4103/ijo.IJO_1682_20.Nayak B., Poddar C., Panigrahi M.K., Tripathy S., Mishra B. Late manifestation of follicular conjunctivitis in ventilated patient following COVID-19 positive severe pneumonia. Indian J. Ophthalmol. 2020; 68 (8): 1675–7. doi:10.4103/ijo.IJO_1682_20.Belser J.A., Rota P.A., Tumpey T.M. Ocular tropism of respiratory viruses. Microbiol. Mol. Biol. Rev. 2013; 77 (1): 144–56. doi:10.1128/MMBR.00058-12Belser J.A., Rota P.A., Tumpey T.M. Ocular tropism of respiratory viruses. Microbiol. Mol. Biol. Rev. 2013; 77 (1): 144–56. doi:10.1128/MMBR.00058-12Baughman B.D., Hansemann B.K., Shah M.M., Weizer J.S. Drive-through intraocular pressure checks during the COVID-19 pandemic. J Glaucoma. 2021; 30 (3): 223–6. doi:10.1097/IJG.0000000000001748Baughman B.D., Hansemann B.K., Shah M.M., Weizer J.S. Drive-through intraocular pressure checks during the COVID-19 pandemic. J Glaucoma. 2021; 30 (3): 223–6. doi:10.1097/IJG.0000000000001748Jain N., Kaur S., Kopsachilis N., Zia R. Risk of airborne COVID-19 transmission while performing Humphrey visual field testing. J. Glaucoma. 2021; 30 (3): 219–22. doi:10.1097/IJG.0000000000001771Jain N., Kaur S., Kopsachilis N., Zia R. Risk of airborne COVID-19 transmission while performing Humphrey visual field testing. J. Glaucoma. 2021; 30 (3): 219–22. doi:10.1097/IJG.0000000000001771Napoli P.E., Nioi M., d’Aloja E., Fossarello M. Safety recommendations and medical liability in ocular surgery during the COVID-19 pandemic: an unsolved dilemma. J. Clin. Med. 2020; 9 (5): 1403. doi:10.3390/jcm9051403Napoli P.E., Nioi M., d’Aloja E., Fossarello M. Safety recommendations and medical liability in ocular surgery during the COVID-19 pandemic: an unsolved dilemma. J. Clin. Med. 2020; 9 (5): 1403. doi:10.3390/jcm9051403Casagrande M., Fitzek A., Spitzer M.S., et al. Presence of SARSCoV-2 RNA in the cornea of viremic patients with COVID-19. JAMA Ophthalmol. 2021; 139 (4): 383–8. doi:10.1001/jamaophthalmol.2020.6339Casagrande M., Fitzek A., Spitzer M.S., et al. Presence of SARSCoV-2 RNA in the cornea of viremic patients with COVID-19. JAMA Ophthalmol. 2021; 139 (4): 383–8. doi:10.1001/jamaophthalmol.2020.6339Aggarwal K., Agarwal A., Jaiswal N., et al. Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. PLoS One. 2020; 15 (11): e0241661. doi:10.1371/journal.pone.0241661Aggarwal K., Agarwal A., Jaiswal N., et al. Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. PLoS One. 2020; 15 (11): e0241661. doi:10.1371/journal.pone.0241661Sindhuja K., Lomi N., Asif M.I., Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J. Ophthalmol. 2020; 68 (8): 1546–50. doi:10.4103/ijo.IJO_1319_20Sindhuja K., Lomi N., Asif M.I., Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J. Ophthalmol. 2020; 68 (8): 1546–50. doi:10.4103/ijo.IJO_1319_20Guo D., Xia J., Wang Y., et al. Relapsing viral keratoconjunctivitis in COVID-19: a case report. Virol. J. 2020; 17 (1): 97. doi:10.1186/s12985-020-01370-6Guo D., Xia J., Wang Y., et al. Relapsing viral keratoconjunctivitis in COVID-19: a case report. Virol. J. 2020; 17 (1): 97. doi:10.1186/s12985-020-01370-6Navel V., Chiambaretta F., Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am. J. Ophthalmol Case Rep. 2020; 19: 100735. doi:10.1016/j.ajoc.2020.100735Navel V., Chiambaretta F., Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am. J. Ophthalmol Case Rep. 2020; 19: 100735. doi:10.1016/j.ajoc.2020.100735Otaif W., Al Somali A.I., Al Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: A case report. Am. J. Ophthalmol. Case Rep. 2020; 20: 100917. doi:10.1016/j.ajoc.2020.100917Otaif W., Al Somali A.I., Al Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: A case report. Am. J. Ophthalmol. Case Rep. 2020; 20: 100917. doi:10.1016/j.ajoc.2020.100917Mangana C.M., Kargacin A.B., Barraquer R.I. Episcleritis as an ocular manifestation in a patient with COVID-19. Acta Ophthalmol. 2020; 98 (8): e1056–7. doi:10.1111/aos.14484Mangana C.M., Kargacin A.B., Barraquer R.I. Episcleritis as an ocular manifestation in a patient with COVID-19. Acta Ophthalmol. 2020; 98 (8): e1056–7. doi:10.1111/aos.14484Meduri A., Oliverio G.W., Mancuso G., et al. Ocular surface manifestation of COVID-19 and tear film analysis. Sci Rep. 2020; 10 (1): 20178. doi:10.1038/s41598-020-77194-9Meduri A., Oliverio G.W., Mancuso G., et al. Ocular surface manifestation of COVID-19 and tear film analysis. Sci Rep. 2020; 10 (1): 20178. doi:10.1038/s41598-020-77194-9Sen M., Honavar S.G., Sharma N., Sachdev M.S. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J. Ophthalmol. 2021; 69 (3): 488–509. doi:10.4103/ijo.IJO_297_21Sen M., Honavar S.G., Sharma N., Sachdev M.S. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J. Ophthalmol. 2021; 69 (3): 488–509. doi:10.4103/ijo.IJO_297_21Scalinci S.Z., Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. 2020; 20: e00774. doi:10.1016/j.idcr.2020.e00774Scalinci S.Z., Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. 2020; 20: e00774. doi:10.1016/j.idcr.2020.e00774Guan W.J., Ni Z.Y., Hu Y., et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J Med. 2020; 382 (18): 1708–20. doi:10.1056/NEJMoa2002032Guan W.J., Ni Z.Y., Hu Y., et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J Med. 2020; 382 (18): 1708–20. doi:10.1056/NEJMoa2002032Colavita F., Lapa D., Carletti F., et al. SARS-CoV-2 Isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann. Intern. Med. 2020; 173 (3): 242–3. doi:10.7326/M20-1176Colavita F., Lapa D., Carletti F., et al. SARS-CoV-2 Isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann. Intern. Med. 2020; 173 (3): 242–3. doi:10.7326/M20-1176Daruich A., Martin D., Bremond-Gignac D. Unilateral conjunctivitis as first presentation of Coronavirus Disease 2019 (COVID-19): A telemedicine diagnosis. J. Fr. Ophtalmol. 2020; 43 (5): e167–8. doi:10.1016/j.jfo.2020.04.001Daruich A., Martin D., Bremond-Gignac D. Unilateral conjunctivitis as first presentation of Coronavirus Disease 2019 (COVID-19): A telemedicine diagnosis. J. Fr. Ophtalmol. 2020; 43 (5): e167–8. doi:10.1016/j.jfo.2020.04.001Khavandi S., Tabibzadeh E., Naderan M., Shoar S. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic. Cont. Lens Anterior Eye. 2020; 43 (3): 211–2. doi:10.1016/j.clae.2020.04.010Khavandi S., Tabibzadeh E., Naderan M., Shoar S. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic. Cont. Lens Anterior Eye. 2020; 43 (3): 211–2. doi:10.1016/j.clae.2020.04.010Salducci M., La Torre G. COVID-19 emergency in the cruise's ship: a case report of conjunctivitis. Clin. Ter. 2020; 171 (3): e189–91. doi:10.7417/CT.2020.2212Salducci M., La Torre G. COVID-19 emergency in the cruise's ship: a case report of conjunctivitis. Clin. Ter. 2020; 171 (3): e189–91. doi:10.7417/CT.2020.2212Atum M., Boz A.A.E., ak r B., et al. Evaluation of conjunctival swab PCR results in patients with SARS-CoV-2 infection. Ocul. Immunol. Inflam. 2020; 28 (5): 745–8. doi:10.1080/09273948.2020.1775261Atum M., Boz A.A.E., ak r B., et al. Evaluation of conjunctival swab PCR results in patients with SARS-CoV-2 infection. Ocul. Immunol. Inflam. 2020; 28 (5): 745–8. doi:10.1080/09273948.2020.1775261Lan Q.Q., Zeng S.M., Liao X., et al. A special on epidemic prevention and control: screening for novel coronavirus related conjunctivitis among the patients with coronavirus disease 2019. Zhonghua Yan Ke Za Zhi. 2020; 56 (6): 433–7. doi:10.3760/cma.j.cn112142-20200322-00213Lan Q.Q., Zeng S.M., Liao X., et al. A special on epidemic prevention and control: screening for novel coronavirus related conjunctivitis among the patients with coronavirus disease 2019. Zhonghua Yan Ke Za Zhi. 2020; 56 (6): 433–7. doi:10.3760/cma.j.cn112142-20200322-00213Karimi S., Arabi A., Shahraki T., Safi S. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019. Eye (Lond). 2020; 34 (7): 1220–3. doi:10.1038/s41433-020-0965-2Karimi S., Arabi A., Shahraki T., Safi S. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019. Eye (Lond). 2020; 34 (7): 1220–3. doi:10.1038/s41433-020-0965-2Goel R., Arora R., Chhabra M., Kumar S. Viral shedding in tears of COVID-19 cases presenting as conjunctivitis. Indian J. Ophthalmol. 2020; 68 (10): 2308. doi:10.4103/ijo.IJO_2567_20Goel R., Arora R., Chhabra M., Kumar S. Viral shedding in tears of COVID-19 cases presenting as conjunctivitis. Indian J. Ophthalmol. 2020; 68 (10): 2308. doi:10.4103/ijo.IJO_2567_20Tyagi R., Dadia S., Sharma S., et al. Ocular manifestations in Covid-19 positive patients admitted to a Tertiary care centre in Uttarakhand, India: A prospective study. International J. Health and Clinical Research. 2021; 4 (6): 225–8.Tyagi R., Dadia S., Sharma S., et al. Ocular manifestations in Covid-19 positive patients admitted to a Tertiary care centre in Uttarakhand, India: A prospective study. International J. Health and Clinical Research. 2021; 4 (6): 225–8.Bostanci Ceran B., Ozates S. Ocular manifestations of coronavirus disease 2019. Graefes Arch. Clin. Exp. Ophthalmol. 2020; 258 (9): 1959–63. doi:10.1007/s00417-020-04777-7Bostanci Ceran B., Ozates S. Ocular manifestations of coronavirus disease 2019. Graefes Arch. Clin. Exp. Ophthalmol. 2020; 258 (9): 1959–63. doi:10.1007/s00417-020-04777-7

The authors declare that there are no conflicts of interest present.